Please login to the form below

Not currently logged in
Email:
Password:

Open Health appoints Trish Shepherd as global business director

She joins the group from Ogilvy CommonHealth Worldwide

Open Health Trish ShepherdOpen Health has appointed Trish Shepherd as its global business director to drive service integration for its global clients from centres in the UK, US and Dubai.

She arrives at the Buckinghamshire, UK-based group of agencies from Ogilvy CommonHealth Worldwide, where she spent eight years, most recently serving as group business director.

During her time there Shepherd held a global brand leadership role for the network and she has also held senior global and EU roles for brands across a broad range of pharmaceutical and wellness therapy areas.

Open Health’s chief operating officer Sandy Royden said: “As one of Europe’s largest healthcare groups servicing leading global healthcare brands, we see global client stewardship as a business imperative to our future success.

“Building deeper, strategic partnerships will enable us to identify the right mix of best-in-class services and deliver added value and efficiency for our clients.”

Formed in 2011, Open Health’s roster of agencies includes The Earthworks, LEC and Reynolds Mackenzie.

31st July 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics